Endometrial Stromal Sarcomas: Clinical Trials

1 completed. 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	1	Completed 1

Follow Endometrial Stromal Sarcomas: new trials by email Literature Review of Endometrial Stromal Sarcomas trials Research Report on Endometrial Stromal Sarcomas

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 MRI, CT or ultrasound was permitted if MRI was contraindicated, Dexamethasone Supression Test, Sonogram - Adrenocortical Adenoma, Endometrial Stromal Sarcomas	Phase 2	Completed	Novartis Pharmaceuticals	59	2014-08-01	2016-12-05

Narrower conditions

Adrenocortical Adenoma (1)  ·  Sarcoma, Endometrial Stromal (1)

Broader conditions

Adrenal Cortex Diseases (1)  ·  Adrenal Cortex Neoplasms (1)  ·  Adrenal Gland Diseases (1)  ·  Adrenal Gland Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Endometrial Neoplasms (1)  ·  Endometrial Stromal Tumors (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Genital Neoplasms, Female (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Biopsy (1)  ·  High-Energy Shock Waves (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Postmortem Imaging (1)  ·  selurampanel (1)

Sponsors

Novartis Pharmaceuticals (1)

Countries

Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Slovakia (1)  ·  South Korea (1)  ·  United States (1)